Psychedelic-Assisted Therapy

Here you can find information about ethics and safety, and the typical treatment trajectories and therapeutic process for psychedelic-assisted therapy.

Please be advised that access to legal, guided psychedelic-assisted therapy in Canada requires a Special Access approval from Health Canada. However, discussion about the use of psychedelic medicine, such as psilocybin (mushrooms) and MDMA (3,4-Methyl​enedioxy​methamphetamine), is welcome and will be addressed within a non-judgmental and harm-reduction approach.

Safety and Ethics

Finding the right psychedelic-medicine guide is important! Click below for the Code of Ethics outlined by the Psychedelic Association of Canada, as well as a guideline for how to identify red flags.

Typical Treatment Trajectory

Click below to learn more about a typical treatment trajectory in the event that you’re eligible for psychedelic-assisted therapy. Please note, that doctor’s may have their own fees related to assessments and Health Canada application costs.

Research and Credibility

Although plant medicines have been used for millennia to treat many different ailments and conditions, new research is emerging regarding its efficacy and credibility. Click below to learn more about what is being discovered.